SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

242.5445604

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

41.7

14580.18

EPS(TTM)

Face Value()

Div & Yield %

0.31

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	752.41	625.09	528.61	528.06	482.68	527.83
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	752.41	625.09	528.61	528.06	482.68	527.83
Other Income	134.59	105.84	99.00	56.55	18.62	65.97
Stock Adjustments	-24.36	43.68	1.67	9.00	0.57	0.74
Total Income	862.64	774.61	629.28	593.61	501.87	594.54
EXPENDITURE :
Raw Materials	213.81	248.90	199.73	213.65	195.40	238.92
Power & Fuel Cost	14.11	15.43	9.89	9.54	6.36	7.19
Employee Cost	52.13	38.11	36.68	30.47	26.59	25.00
Other Manufacturing Expenses	24.00	25.43	13.73	10.81	7.75	8.98
Selling & Administrative Expenses	75.50	40.75	40.30	43.51	28.12	38.19
Miscellaneous Expenses	16.53	13.07	10.03	9.46	5.10	3.29
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	396.08	381.69	310.36	317.44	269.32	321.57
Operating Profit	466.56	392.92	318.92	276.17	232.55	272.97
Interest	0.12	0.10	0.12	0.09	0.17	0.19
Gross Profit	466.44	392.82	318.80	276.08	232.38	272.78
Depreciation	24.77	27.08	25.65	25.77	22.44	19.65
Profit Before Tax	441.67	365.74	293.15	250.31	209.94	253.13
Tax	102.90	86.12	66.58	61.62	54.88	55.89
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.72	-4.09	-7.69	0.82	-1.17	-0.40
Reported Net Profit	339.49	283.71	234.26	187.87	156.23	197.64
Extraordinary Items	-0.33	1.19	1.17	0.75	4.67	3.75
Adjusted Net Profit	339.82	282.52	233.09	187.12	151.56	193.89
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	1333.49	1083.95	880.01	714.84	561.64	396.53
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	37.99	34.17	30.32	22.70	3.03	32.53
P & L Balance carried down	1634.99	1333.49	1083.95	880.01	714.84	561.64
Dividend	18.99	15.19	15.16	11.35	0.00	15.88
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	300.00	250.00	225.00	200.00	150.00	125.00
Dividend Per Share(Rs)	6.00	5.00	4.50	4.00	3.00	2.50
Earnings Per Share-Unit Curr	44.67	37.35	30.86	24.78	20.65	26.13
Earnings Per Share(Adj)-Unit Curr	44.67	37.35	30.86	24.78	20.65	26.13
Book Value-Unit Curr	223.81	183.03	150.19	122.78	100.29	79.31
Book Value(Adj)-Unit Curr	223.81	183.03	150.19	122.78	100.29	79.31

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)